Pharm Tech Agenda 2015.06.05: Difference between revisions
Jump to navigation
Jump to search
| Line 22: | Line 22: | ||
=== Review of CP documents === | === Review of CP documents === | ||
[ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/PRE%20Public%20Comment All Drafts are here | * [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/PRE%20Public%20Comment All Drafts are here] | ||
* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/PRE%20Public%20Comment/CP-PHARM-101v2.docx Definition of the MTP Item and introduction of the possibility | * [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/PRE%20Public%20Comment/Readme.txt Readme] | ||
* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTreatmentPlan,%20MTP/PRE%20Public%20Comment/CP-PHARM-101v2.docx Definition of the MTP Item and introduction of the possibility for PRE and DIS items to reference a planning action (MTP Item)] | |||
** Status: | ** Status: | ||
Latest revision as of 02:08, 5 June 2015
Meeting details
Friday, 5 June 2015, 14:00 CET
WebEx details:
Meeting number: 951 235 855
JOIN BY PHONE
+33 17091 8646 France toll
0800-9-19312 France toll free
Call-in Numbers: Global Call-in numbers
Access code: 951 235 855
Agenda
Review of CP documents
- MTP Profile
- Status:
- Next steps